Owens & Minor Inc (NYSE OMI) reported fourth-quarter 2023 adjusted EPS of $0.69, up from $0.28 a year ago and beating the consensus of $0.66. Revenues increased 4% year-on-year (Y/Y) to $2.66 billion, in line with the consensus. Patient Direct revenue of $664 million increased 8% Y/Y from strong growth in several product categories. Products & Healthcare Services revenue of nearly $2 billion, up 3% compared to the fourth quarter of 2022, with growth in both the Medical Distribution and Global Pr
Top Line Expansion Led by Healthy Demand in Patient Direct and Medical Distribution
Operating Cash Flow Generation Supported $188 million in Total Debt Reduction
.